Nuciferine Relaxes Rat Mesenteric Arteries Through Endothelium-Dependent and -Independent Mechanisms

Xinfeng Wang,Wai San Cheang,Haixia Yang,Lei Xiao,Baochang Lai,Meiqian Zhang,Jiahua Ni,Zhenyu Luo,Zihui Zhang,Yu Huang,Nanping Wang
DOI: https://doi.org/10.1111/bph.13021
IF: 7.3
2015-01-01
British Journal of Pharmacology
Abstract:Background and PurposeNuciferine, a constituent of lotus leaf, is an aromatic ring‐containing alkaloid, with antioxidative properties. We hypothesize nuciferine might affect vascular reactivity. This study aimed at determining the effects of nuciferine on vasomotor tone and the underlying mechanismExperimental ApproachNuciferine‐induced relaxations in rings of rat main mesenteric arteries were measured by wire myographs. Endothelial NOS (eNOS) was determined by immunoblotting. Intracellular NO production in HUVECs and Ca2+ level in both HUVECs and vascular smooth muscle cells (VSMCs) from rat mesenteric arteries were assessed by fluorescence imaging.Key ResultsNuciferine induced relaxations in arterial segments pre‐contracted by KCl or phenylephrine. Nuciferine‐elicited arterial relaxations were reduced by removal of endothelium or by pretreatment with the eNOS inhibitor L‐NAME or the NO‐sensitive guanylyl cyclase inhibitor ODQ. In HUVECs, the phosphorylation of eNOS at Ser1177 and increase in cytosolic NO level induced by nuciferine were mediated by extracellular Ca2+ influx. Under endothelium‐free conditions, nuciferine attenuated CaCl2‐induced contraction in Ca2+‐free depolarizing medium. In the absence of extracellular calcium, nuciferine relieved the vasoconstriction induced by phenylephrine and the addition of CaCl2. Nuciferine also suppressed Ca2+ influx in Ca2+‐free K+‐containing solution in VSMCs.Conclusions and ImplicationsNuciferine has a vasorelaxant effect via both endothelium‐dependent and ‐independent mechanisms. These results suggest that nuciferine may have a therapeutic effect on vascular diseases associated with aberrant vasoconstriction.Linked ArticlesThis article is part of a themed section on Chinese Innovation in Cardiovascular Drug Discovery. To view the other articles in this section visit http://dx.doi.org/10.1111/bph.2015.172.issue-23
What problem does this paper attempt to address?